US4904479A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug delivery system
Assignee: Kyowa Kirin Services Ltd
•
Filing: 1987-01-15
•
Granted: 1990-02-27
•
Expires: 2007-01-15
Abstract
Abstract Particles of a drug are directed away from the reticuloendothelial system by the use of surface coating and surface grafting techniques which substantially prevent the take up of the composite particles by the liver.
Inventors
- 👤 Lisbeth Illum
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:45
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5146; A61K9/10; A61K9/127; A61K9/1271; A61K9/5005; A61K9/5021; A61K9/5031
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
44 words
A drug delivery system comprising an active drug as a suspension of colloidal particles, each particle being coated with a material which provides a hydrophilic coat having a thickness of from 100 Å to 154 Å and a steric barrier to particle cell interaction.
Claim 2
Dependent Claim
44 words
A drug delivery system comprising an active drug as a suspension of colloidal particles, each particle being coated with a material which provides a hydrophilic coat having a thickness of from 100 Å to 154 Å and a steric barrier to particle cell interaction.
Claim 3
Dependent Claim
31 words
A drug delivery system as claimed in claim 1 in which the coating material is a polymer which is selected to provide an electrostatic barrier as well as said steric barrier.
Claim 4
Dependent Claim
36 words
A drug delivery system as claimed in claim 1 in which the coating material is a polyoxypropylene/polyoxyethylene/ethylenediamine block co-polymer having 9 units of polyoxypropylene and an average weight percentage of 80% polyoxyethylene known as poloxamine 908.
Claim 5
Dependent Claim
37 words
A drug delivery system as claimed in claim 1 in which the coating material is a polyoxypropylene/polyoxyethylene/propylene glycol block co-polymer having 4 units of polyoxypropylene and an average weight percentage of 70% polyoxyethylene known as poloxamer 407.
Claim 6
Dependent Claim
68 words
A drug delivery system in particulate form which following reconstitution is suitable for injection as a suspension of colloidal particles, said system comprising a plurality of composite particles with each particle comprising an active drug in particulate form coated with a material which provides a hydrophilic coat having a thickness in the range of from 100 Å to 154 Å and a steric barrier to particle cell interaction.
Claim 7
Dependent Claim
68 words
A drug delivery system in particulate form which following reconstitution is suitable for injection as a suspension of colloidal particles, said system comprising a plurality of composite particles with each particle comprising an active drug in particulate form coated with a material which provides a hydrophilic coat having a thickness in the range of from 100 Å to 154 Å and a steric barrier to particle cell interaction.
References Cited (Backward Citations)
US3867521A
Cited
US4668704A
Cited
US4670468A
Cited
US4556670A
Cited
US4474751A
Cited
US4474753A
Cited
US4474752A
Cited
US4478822A
Cited
US4620974A
Cited
US4533542A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-02-26 | 1993-08-28 | 1994-02-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-02-26 | 1997-08-28 | 1998-02-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-02-26 | 2001-08-28 | 2002-02-27 | $7700.00 | Window Closed / Lapsed |